A novel MCF-10A line allowing conditional oncogene expression in 3D culture

Cell Communication and Signaling

Volumn 9, Issue , 2011, Pages

  Herr, Ricarda ^a   Wöhrle, Franziska U ^a   Danke, Christina ^c   Berens, Christian ^c   Brummer, Tilman ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

apoptosis; BRAF; carcinogenesis; Caspase 3; E Cadherin; epithelial mesenchymal transition (EMT); KI 67; mammary epithelium; MCF 10A; tetracycline inducible gene expression system

Indexed keywords

B RAF KINASE; DOXYCYCLINE;

ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE PROGRESSION; CELL STRAIN MCF 10A; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME REACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; MORPHOLOGY; ONCOGENE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; TRANSGENE;

EID: 79960119681     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-9-17     Document Type: Article

References (55)

1. Modelling glandular epithelial cancers in three-dimensional cultures. J Debnath, JS Brugge, Nat Rev Cancer 2005 5 675 688 10.1038/nrc1695 16148884 (Pubitemid 41486361)
2. Opinion: Building epithelial architecture: insights from three-dimensional culture models. LE O'Brien, MM Zegers, KE Mostov, Nat Rev Mol Cell Biol 2002 3 531 537 10.1038/nrm859 12094219 (Pubitemid 34733434)
3. Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. NJ Godde, RC Galea, IA Elsum, PO Humbert, J Mammary Gland Biol Neoplasia 2010 15 149 168 10.1007/s10911-010-9180-2 20461450
4. Modeling tissue-specific signaling and organ function in three dimensions. KL Schmeichel, MJ Bissell, J Cell Sci 2003 116 2377 2388 10.1242/jcs.00503 12766184 (Pubitemid 36790120)
5. Modeling tissue morphogenesis and cancer in 3D. KM Yamada, E Cukierman, Cell 2007 130 601 610 10.1016/j.cell.2007.08.006 17719539 (Pubitemid 47268064)
6. A tense situation: forcing tumour progression. DT Butcher, T Alliston, VM Weaver, Nat Rev Cancer 2009 9 108 122 10.1038/nrc2544 19165226
7. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. J Debnath, KR Mills, NL Collins, MJ Reginato, SK Muthuswamy, JS Brugge, Cell 2002 111 29 40 10.1016/S0092- 8674(02)01001-2 12372298
8. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. J Debnath, SK Muthuswamy, JS Brugge, Methods 2003 30 256 268 10.1016/S1046-2023(03)00032-X 12798140 (Pubitemid 36677560)
9. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. J Debnath, SJ Walker, JS Brugge, J Cell Biol 2003 163 315 326 10.1083/jcb.200304159 14568991 (Pubitemid 37363132)
10. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. V Aranda, T Haire, ME Nolan, JP Calarco, AZ Rosenberg, JP Fawcett, T Pawson, SK Muthuswamy, Nat Cell Biol 2006 8 1235 1245 10.1038/ncb1485 17060907 (Pubitemid 44660588)
11. Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction. M Jechlinger, K Podsypanina, H Varmus, Genes Dev 2009 23 1677 1688 10.1101/gad.1801809 19605689
12. Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells. GW Pearson, T Hunter, J Cell Biol 2007 179 1555 1567 10.1083/jcb.200706099 18166657
13. Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo. A Beliveau, JD Mott, A Lo, EI Chen, AA Koller, P Yaswen, J Muschler, MJ Bissell, Genes Dev 2010 24 2800 2811 10.1101/gad.1990410 21159820
14. Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. T Brummer, D Schramek, VM Hayes, HL Bennett, CE Caldon, EA Musgrove, RJ Daly, J Biol Chem 2006 281 626 637 16253990 (Pubitemid 43671226)
15. Adjusting transgene expression levels in lymphocytes with a set of inducible promoters. C Danke, X Grunz, J Wittmann, A Schmidt, S Agha-Mohammadi, O Kutsch, HM Jack, W Hillen, C Berens, J Gene Med 2010 12 501 515 10.1002/jgm.1461 20527043
16. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. S Urlinger, U Baron, M Thellmann, MT Hasan, H Bujard, W Hillen, Proc Natl Acad Sci USA 2000 97 7963 7968 10.1073/pnas.130192197 10859354 (Pubitemid 30460756)
17. Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. C Berens, W Hillen, Eur J Biochem 2003 270 3109 3121 10.1046/j.1432-1033.2003.03694.x 12869186 (Pubitemid 36930176)
18. A gene regulation system with four distinct expression levels. C Krueger, C Danke, K Pfleiderer, W Schuh, HM Jack, S Lochner, P Gmeiner, W Hillen, C Berens, J Gene Med 2006 8 1037 1047 10.1002/jgm.932 16779863 (Pubitemid 44283000)
19. BRAF(E600) in benign and malignant human tumours. C Michaloglou, LC Vredeveld, WJ Mooi, DS Peeper, Oncogene 2008 27 877 895 10.1038/sj.onc.1210704 17724477 (Pubitemid 351225383)
20. Raf Family Kinases: Old Dogs Have Learned New Tricks. D Matallanas, M Birtwistle, D Romano, A Zebisch, J Rauch, A Von Kriegsheim, W Kolch, Genes & Cancer 2011 21761563
21. Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. I Menashe, D Maeder, M Garcia-Closas, JD Figueroa, S Bhattacharjee, M Rotunno, P Kraft, DJ Hunter, SJ Chanock, PS Rosenberg, N Chatterjee, Cancer Res 2010 70 4453 4459 10.1158/0008-5472.CAN-09-4502 20460509
22. Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines. A Hollestelle, F Elstrodt, JH Nagel, WW Kallemeijn, M Schutte, Mol Cancer Res 2007 5 195 201 10.1158/1541-7786.MCR-06-0263 17314276 (Pubitemid 46424000)
23. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. A Hollestelle, JH Nagel, M Smid, S Lam, F Elstrodt, M Wasielewski, SS Ng, PJ French, JK Peeters, MJ Rozendaal, M Riaz, DG Koopman, TL Ten Hagen, BH de Leeuw, EC Zwarthoff, A Teunisse, PJ van der Spek, JG Klijn, WN Dinjens, SP Ethier, H Clevers, AG Jochemsen, MA den Bakker, JA Foekens, JW Martens, M Schutte, Breast Cancer Res Treat 2010 121 53 64 10.1007/s10549-009- 0460-8 19593635
24. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. OK Mirzoeva, D Das, LM Heiser, S Bhattacharya, D Siwak, R Gendelman, N Bayani, NJ Wang, RM Neve, Y Guan, Z Hu, Z Knight, HS Feiler, P Gascard, B Parvin, PT Spellman, KM Shokat, AJ Wyrobek, MJ Bissell, F McCormick, WL Kuo, GB Mills, JW Gray, WM Korn, Cancer Res 2009 69 565 572 10.1158/0008-5472.CAN-08- 3389 19147570
25. Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein. T Brummer, P Martin, S Herzog, Y Misawa, RJ Daly, M Reth, Oncogene 2006 25 6262 6276 10.1038/sj.onc.1209640 16702958 (Pubitemid 44564743)
26. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. G Bollag, P Hirth, J Tsai, J Zhang, PN Ibrahim, H Cho, W Spevak, C Zhang, Y Zhang, G Habets, EA Burton, B Wong, G Tsang, BL West, B Powell, R Shellooe, A Marimuthu, H Nguyen, KY Zhang, DR Artis, J Schlessinger, F Su, B Higgins, R Iyer, K D'Andrea, A Koehler, M Stumm, PS Lin, RJ Lee, al Grippo J et, Nature 2010 467 596 599 10.1038/nature09454 20823850
27. The Ki-67 protein: from the known and the unknown. T Scholzen, J Gerdes, J Cell Physiol 2000 182 311 322 10.1002/(SICI)1097-4652(200003)182:3<311:: AID-JCP1>3.0.CO;2-9 10653597 (Pubitemid 30054364)
28. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. SK Muthuswamy, D Li, S Lelievre, MJ Bissell, JS Brugge, Nat Cell Biol 2001 3 785 792 10.1038/ncb0901-785 11533657 (Pubitemid 32842683)
29. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. CN Wrobel, J Debnath, E Lin, S Beausoleil, MF Roussel, JS Brugge, J Cell Biol 2004 165 263 273 10.1083/jcb.200309102 15117969 (Pubitemid 38544529)
30. Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. JA Wickenden, H Jin, M Johnson, AS Gillings, C Newson, M Austin, SD Chell, K Balmanno, CA Pritchard, SJ Cook, Oncogene 2008 27 7150 7161 10.1038/onc.2008.335 18806830
31. Illuminating the center: mechanisms regulating lumen formation and maintenance in mammary morphogenesis. MJ Reginato, SK Muthuswamy, J Mammary Gland Biol Neoplasia 2006 11 205 211 10.1007/s10911-006-9030-4 17115263 (Pubitemid 44869916)
32. A novel role for 14-3-3sigma in regulating epithelial cell polarity. C Ling, D Zuo, B Xue, S Muthuswamy, WJ Muller, Genes Dev 2010 24 947 956 10.1101/gad.1896810 20439433
33. CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture. J Kirshner, CJ Chen, P Liu, J Huang, JE Shively, Proc Natl Acad Sci USA 2003 100 521 526 10.1073/pnas.232711199 12522268 (Pubitemid 36126084)
34. Epithelial-mesenchymal transitions in development and disease. JP Thiery, H Acloque, RY Huang, MA Nieto, Cell 2009 139 871 890 10.1016/j.cell.2009.11.007 19945376
35. The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer? S Brabletz, T Brabletz, EMBO Rep 2010 11 670 677 10.1038/embor.2010.117 20706219
36. Adaptation versus selection: the origins of metastatic behavior. C Scheel, T Onder, A Karnoub, RA Weinberg, Cancer Res 2007 67 11476 11479; discussion 11479-11480 10.1158/0008-5472.CAN-07-1653 18089773
37. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. K Polyak, RA Weinberg, Nat Rev Cancer 2009 9 265 273 10.1038/nrc2620 19262571
38. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. SK Muthuswamy, M Gilman, JS Brugge, Mol Cell Biol 1999 19 6845 6857 10490623 (Pubitemid 29441868)
39. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. CA Pritchard, ML Samuels, E Bosch, M McMahon, Mol Cell Biol 1995 15 6430 6442 7565795
40. Regulation of cellular proliferation, differentiation and cell death by activated Raf. G Thiel, M Ekici, OG Rossler, Cell Commun Signal 2009 7 8 10.1186/1478-811X-7-8 19383130
41. The RAF proteins take centre stage. C Wellbrock, M Karasarides, R Marais, Nat Rev Mol Cell Biol 2004 5 875 885 10.1038/nrm1498 15520807 (Pubitemid 39486539)
42. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells. J Chen, EM Miller, KA Gallo, Oncogene 2010 29 4399 4411 10.1038/onc.2010.198 20514022
43. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. MJ Reginato, KR Mills, EB Becker, DK Lynch, A Bonni, SK Muthuswamy, JS Brugge, Mol Cell Biol 2005 25 4591 4601 10.1128/MCB.25.11.4591- 4601.2005 15899862 (Pubitemid 40705763)
44. BAG-1 overexpression attenuates luminal apoptosis in MCF-10A mammary epithelial cells through enhanced RAF-1 activation. LR Anderson, RL Sutherland, AJ Butt, Oncogene 2010 29 527 538 10.1038/onc.2009.362 19881545
45. PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture. GW Pearson, T Hunter, Breast Cancer Res 2009 11 29 10.1186/bcr2259 19457236
46. Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis. HL Bennett, T Brummer, A Jeanes, AS Yap, RJ Daly, Oncogene 2008 27 2693 2704 10.1038/sj.onc.1210928 17998934 (Pubitemid 351581464)
47. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs. KI Patterson, T Brummer, RJ Daly, PM O'Brien, Biochim Biophys Acta 2010 1803 1003 1012 10.1016/j.bbamcr. 2010.03.014 20347885
48. Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein. T Brummer, M Larance, MT Abreu, RJ Lyons, P Timpson, CH Emmerich, ED Fleuren, GM Lehrbach, D Schramek, M Guilhaus, DE James, RJ Daly, Embo J 2008 27 2305 2316 10.1038/emboj.2008.159 19172738
49. Use of the human EF-1α promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. RV Gopalkrishnan, KA Christiansen, NI Goldstein, RA DePinho, PB Fisher, Nucleic Acids Res 1999 27 4775 4782 10.1093/nar/27.24.4775 10572178 (Pubitemid 30006668)
50. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. AE Eisenhardt, H Olbrich, M Roring, W Janzarik, TN Van Anh, H Cin, M Remke, H Witt, A Korshunov, SM Pfister, H Omran, T Brummer, Int J Cancer 2010 10.1002/ijc.25893 21190184
51. Mutant loxP vectors for selectable marker recycle and conditional knock-outs. H Arakawa, D Lodygin, JM Buerstedde, BMC Biotechnol 2001 1 7 10.1186/1472-6750-1-7 11591226 (Pubitemid 38846427)
52. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. M Gossen, H Bujard, Proc Natl Acad Sci USA 1992 89 5547 5551 10.1073/pnas.89.12.5547 1319065
53. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness. S Agha-Mohammadi, M O'Malley, A Etemad, Z Wang, X Xiao, MT Lotze, J Gene Med 2004 6 817 828 10.1002/jgm.566 15241789 (Pubitemid 40228098)
54. FACS-optimized mutants of the green fluorescent protein (GFP). BP Cormack, RH Valdivia, S Falkow, Gene 1996 173 33 38 10.1016/0378-1119(95)00685-0 8707053 (Pubitemid 26239677)
55. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. HD Soule, TM Maloney, SR Wolman, WD Peterson, R Brenz, CM McGrath, J Russo, RJ Pauley, RF Jones, SC Brooks, Cancer Res 1990 50 6075 6086 1975513 (Pubitemid 20331424)